课题基金 / 基金详情

CHARACTERIZATION OF INDUCED NEUROENDOCRINE LUNG CANCER

CHARACTERIZATION OF INDUCED NEUROENDOCRINE LUNG CANCER
诱发神经内分泌肺癌的特征
批准号:
3191898
负责人:
Hildegard M. Schuller
金额:
$14.56万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1991-06-30

项目摘要

项目成果

Hildegard M. Schuller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuroendocrine lung cancer is one of the most common types of cancer in smokers but has never been induced in an animal. This project is based on the discovery that simultaneous exposure of hamsters to hyperoxia and diethylnitrosamine (DEN) induces a high incidence of neuroendocrine lung cancers while hyperoxia alone, or DEN alone lead to a pronounced increase of pulmonary endocrine cells. This unique in vivo model is of potentially great importance for studies into mechanisms of development of this poorly understood malignancy as well as chemopreventive and therapeutic investigations. However, a prerequisite for all such research is an in-depth characterization of the tumors. The specific aims of this project are: To study the pathology, neuroendocrinology and molecular biology of neuroendocrine lung tumors induced in Syrian golden hamsters by exposure to hyperoxia and DEN and to correlate pathological changes with alterations in neuroendocrine and genetic markers during tumor development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8064258
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
Modulation of cancer prevention by social stress
  • 批准号:
    7809021
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8252196
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    7714157
  • 项目类别:
  • 资助金额:
    $27.27万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
海外基金